Goldman Sachs
ATRS

Goldman Sachs’s Antares Pharma, Inc. ATRS Stock Holding History

Goldman Sachs’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-350,000
Closed -$1.46M – 6754
2013
Q2 		$1.46M Buy
+350,000
New +$1.35M ﹤0.01% 4036

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's ATRS Position: Q2 2022 in Review

Goldman Sachs sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,191,359 shares — an estimated $4.88M sold.

Goldman Sachs first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $5.08M in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Goldman Sachs reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Goldman Sachs sold 1,191,359 Antares Pharma, Inc. shares in Q2 2022, an estimated $4.88M.
  • Goldman Sachs first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
  • Goldman Sachs's Antares Pharma, Inc. position peaked at $5.08M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.